OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Downstaging Concept in Treatment-Resistant Depression: Spotlight on Ketamine
Alina Wilkowska, Wiesław Jerzy Cubała
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14605-14605
Open Access | Times Cited: 13

Showing 13 citing articles:

Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study
Stefania Chiappini, Giacomo d’Andrea, Sergio De Filippis, et al.
European Neuropsychopharmacology (2023) Vol. 74, pp. 15-21
Open Access | Times Cited: 29

Low-carbohydrate diet as a nutritional intervention in a major depression disorder: focus on relapse prevention
Michał Walaszek, Zofia Kachlik, Wiesław Jerzy Cubała
Nutritional Neuroscience (2024), pp. 1-14
Closed Access | Times Cited: 6

Single arketamine in treatment resistant depression: Presentation of 3 cases with regard to sick-leave duration
Adam Włodarczyk, Jakub Słupski, Joanna Szarmach, et al.
Asian Journal of Psychiatry (2024) Vol. 96, pp. 104016-104016
Open Access | Times Cited: 6

Ketamine as Add-On Treatment in Psychotic Treatment-Resistant Depression
Maria Gałuszko‐Węgielnik, Zuzanna Chmielewska, Katarzyna Jakuszkowiak‐Wojten, et al.
Brain Sciences (2023) Vol. 13, Iss. 1, pp. 142-142
Open Access | Times Cited: 14

Inflammation and Treatment-Resistant Depression from Clinical to Animal Study: A Possible Link?
Lara F. Almutabagani, Raghad A. Almanqour, Jawza F. Alsabhan, et al.
Neurology International (2023) Vol. 15, Iss. 1, pp. 100-120
Open Access | Times Cited: 12

Treatment-emergent symptoms during short-term ketamine administration in treatment-resistant bipolar depression: a retrospective cross-sectional descriptive study
Michał Pastuszak, Wiesław Jerzy Cubała, Aleksander Kwaśny
Asian Journal of Psychiatry (2024) Vol. 99, pp. 104159-104159
Closed Access | Times Cited: 4

Short-term ketamine use in bipolar depression: a review of the evidence for short-term treatment management
Alina Wilkowska, Wiesław Jerzy Cubała
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 7

Exploring the Relationship between Mood Disorders and Coexisting Health Conditions: The Focus on Nutraceuticals
Agnieszka Mechlińska, Mariusz S. Wiglusz, Jakub Słupski, et al.
Brain Sciences (2023) Vol. 13, Iss. 9, pp. 1262-1262
Open Access | Times Cited: 5

Low-carbohydrate diet as a disease modifier for relapse prevention of treatment-resistant depression. Spotlight on neuroplasticity and brain-derived neurotrophic factor
Zofia Kachlik, Michał Walaszek, Wiesław Jerzy Cubała
Medical Hypotheses (2024) Vol. 187, pp. 111356-111356
Closed Access

Intravenous Ketamine Infusions in Patients with Depression and Epilepsy: Case Series
Mariusz S. Wiglusz, Zuzanna Chmielewska, Wiesław Jerzy Cubała
(2024)
Closed Access

Molecular Docking Insights into Gatifloxacin Derivatives as Prospective Antidepressant Agents
Priyanka Majalekar, Pramodkumar J. Shirote
Biosciences Biotechnology Research Asia (2024) Vol. 21, Iss. 3, pp. 1255-1264
Open Access

Intravenous ketamine infusions in patients with depression and Epilepsy: Case series
Mariusz S. Wiglusz, Zuzanna Chmielewska, Wiesław Jerzy Cubała
Journal of Clinical Neuroscience (2024) Vol. 130, pp. 110908-110908
Closed Access

Page 1

Scroll to top